Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Map of Alzheimer’s Disease–Signaling Pathways: A Hope for Drug Target Discovery

20 Feb 2013

Abstract excerpt

Alzheimer's disease (AD) is a complex neurodegenerative condition, and its drug therapy is challenging. To inform AD drug discovery, we developed the “AlzPathway,” a prototype of a comprehensive map of AD-related signaling pathways, from information obtained through studies in the public domain. The AlzPathway provides an integrated platform for systems analyses of AD-signaling pathways and networks. Clinical...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 protein interactions
Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23511713
DOI: 10.1038/clpt.2013.37

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Map of Alzheimer’s Disease–Signaling Pathways: A Hope for Drug Target DiscoveryPMID 23511713Read ↗

AlzPathway: a comprehensive map of signaling pathways of Alzheimer's disease.Semantic proximity Read ↗

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read ↗

Interactome mapping suggests new mechanistic details underlying Alzheimer's disease.Semantic proximity Read ↗

Key Regulators of Alzheimer’s Disease: Network Biology and In-Silico Analysis with AChE and Glutamate InhibitorsSemantic proximity Read ↗

A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer diseaseSemantic proximity Read ↗

Network-based Translation of GWAS Findings to Pathobiology and Drug Repurposing for Alzheimer’s DiseaseSemantic proximity Read ↗

An Integrated Molecular Atlas of Alzheimer’s DiseaseSemantic proximity Read ↗

Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.Semantic proximity Read ↗

Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s diseaseSemantic proximity Read ↗

Mining Alzheimer's Interactomes, Macromolecular Complexes and Pathways for drug discoverySemantic proximity Read ↗

Identification of potential drug targets for Alzheimer's disease from genetic insights: A Mendelian randomization study.Semantic proximity Read ↗

Integrated phenotypic and proteomic screening identifies top-tier Alzheimer’s disease therapeutic targetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.